Medical Data Firm Tempus AI Rises After $410.7 Million IPO
- Shares jump up to 18% in first-day trading before paring gains
- Firm employs AI to aid diagnostics for precision medicine
The company’s platform connects laboratory results to a patient’s own clinical data.
Photographer: Pablo Blazquez Dominguez/Getty ImagesThis article is for subscribers only.
Tempus AI Inc., a technology platform company using artificial intelligence to process medical data, jumped as much as 19% in its trading debut before falling closer the price in its $410.7 million initial public offering.
The company’s shares, which opened trading Friday at $40, were up 8.8% to close at $40.25, giving Tempus AI a market value of about $6.6 billion. The company sold 11.1 million shares Thursday at the top of the $35 to $37 marketed range.